Kindred Biosciences (KIN) Tops Q1 EPS by 7c

Kindred Biosciences (NASDAQ: KIN) reported Q1 EPS of ($0.34), $0.07 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c